Evidence map›Paper›PMID 34199634›Full record

ArticleCurrent issues in molecular biology2021

Sevoflurane Modulates AKT Isoforms in Triple Negative Breast Cancer Cells. An Experimental Study.

Crina E Tiron, Emilia Patrașcanu, Paula A Postu, Irina C Vacarean Trandafir, Adrian Tiron, Ioana Grigoras

Open access · goldAbstract read
In one paragraph

Article in Current issues in molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Effects of PropofolFrontiers in oncology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Crina E TironTRANSCEND Research Center, Regional Institute of Oncology, 700483 Iasi, Romania.ORCID 0000-0002-1469-9153
Emilia PatrașcanuDepartment of Anaesthesia and Intensive Care, School of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0002-0646-985X
Paula A PostuTRANSCEND Research Center, Regional Institute of Oncology, 700483 Iasi, Romania.
Irina C Vacarean TrandafirTRANSCEND Research Center, Regional Institute of Oncology, 700483 Iasi, Romania.
Adrian TironTRANSCEND Research Center, Regional Institute of Oncology, 700483 Iasi, Romania.ORCID 0000-0002-7006-5884
Ioana GrigorasDepartment of Anaesthesia and Intensive Care, School of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy, 700115 Iasi, Romania.ORCID 0000-0001-9412-9574
Institutul Regional de Oncologie · ROGrigore T. Popa University of Medicine and Pharmacy · RO

Funding

Universitatea de Medicina și Farmacie Grigore T. Popa - Iasi 3033/28.12.2017
6 · The paper itself

Abstract

(1) Background: Triple negative breast cancer (TNBC) is a highly aggressive tumor, associated with high rates of early distant recurrence and short survival times, and treatment may require surgery, and thus anesthesia. The effects of anesthetic drugs on cancer progression are under scrutiny, but published data are controversial, and the involved mechanisms unclear. Anesthetic agents have been shown to modulate several molecular cascades, including PI3K/AKT/mTOR. AKT isoforms are frequently amplified in various malignant tumors and associated with malignant cell survival, proliferation and invasion. Their activation is often observed in human cancers and is associated with decreased survival rate. Certain anesthetics are known to affect hypoxia cell signaling mechanisms by upregulating hypoxia-inducible factors (HIFs). (2) Methods: MCF-10A and MDA-MB 231 cells were cultivated and CellTiter-Blue

Indexed as

Anesthetics, InhalationCell Culture Techniques, Three DimensionalCell LineCell Line, TumorCell MovementCell ProliferationCell SurvivalFluorescent Antibody TechniqueGene Expression Regulation, NeoplasticHumansHypoxia-Inducible Factor 1, alpha SubunitIntermediate FilamentsProtein IsoformsProto-Oncogene Proteins c-aktReverse Transcriptase Polymerase Chain ReactionSevofluraneAnesthetics, InhalationHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitProtein IsoformsProto-Oncogene Proteins c-aktSevofluraneAKTbreast cancerEMTHIFsevofluranevimentin

Identifiers

PMID34199634
PMCPMC8929147
OpenAlexW3171897950

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.